Journal of Viral Hepatitis

Cover image for Vol. 18 Issue 10

October 2011

Volume 18, Issue 10

Pages 673–744, e408–e608

  1. EDITORIAL

    1. Top of page
    2. EDITORIAL
    3. REVIEW ARTICLE
    4. ORIGINAL ARTICLES
    1. The need for clarity in occult HBV infection (pages 673–674)

      Elliot B. Tapper and Daryl T. Y. Lau

      Article first published online: 14 SEP 2011 | DOI: 10.1111/j.1365-2893.2011.01500.x

  2. REVIEW ARTICLE

    1. Top of page
    2. EDITORIAL
    3. REVIEW ARTICLE
    4. ORIGINAL ARTICLES
    1. Use of HOMA-IR in hepatitis C (pages 675–684)

      M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab and M. Romero-Gomez

      Article first published online: 25 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01474.x

  3. ORIGINAL ARTICLES

    1. Top of page
    2. EDITORIAL
    3. REVIEW ARTICLE
    4. ORIGINAL ARTICLES
    1. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients (pages 685–691)

      M. Sánchez-Conde, P. Miralles, J. María Bellón, D. Rincón, M. Ramírez, I. Gutiérrez, C. Ripoll, J. C. López, J. Cosín, G. Clemente, O. Lo Iacono, R. Bañares and J. Berenguer

      Article first published online: 7 SEP 2010 | DOI: 10.1111/j.1365-2893.2010.01371.x

    2. Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population (pages 692–699)

      B. S. de Almeida, G. M. Fabrício Silva, P. M. da Silva, R. de Mello Perez, F. A. F. Figueiredo and L. C. Porto

      Article first published online: 8 APR 2011 | DOI: 10.1111/j.1365-2893.2010.01429.x

    3. Tobacco and other factors have a negative impact on quality of life in hepatitis C patients (pages 714–720)

      D. Yamini, B. Basseri, G. M. Chee, A. Arakelyan, P. Enayati, T. T. Tran and F. Poordad

      Article first published online: 15 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01361.x

    4. High levels of serum hepatitis B virus DNA in patients with ‘anti-HBc alone’: role of HBsAg mutants (pages 721–729)

      O. Launay, J. Masurel, A. Servant-Delmas, A.-L. Basse-Guérineau, J.-F. Méritet, S. Laperche, P. Sogni and A. R. Rosenberg

      Article first published online: 30 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01482.x

    5. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea (pages e408–e414)

      J.-H. Jang, Y. M. Jung, J. S. Kim, S. H. Lee, J.-W. Kim, S. G. Hwang, K. S. Rim, S. J. Park, Y. M. Park, S.-K. Kang, H. S. Lee, H. Yun, J.-H. Kim and S.-H. Jeong

      Article first published online: 1 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01477.x

    6. Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir (pages e432–e438)

      M. S. Kwak, J. W. Choi, J. S. Lee, K. A. Kim, J. H. Suh, Y. S. Cho, S. Y. Won, B. K. Park and C. K. Lee

      Article first published online: 13 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01461.x

    7. Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line (pages e439–e446)

      Y. Liu, G. Lou, W. Wu, M. Zheng, Y. Shi, D. Zhao and Z. Chen

      Article first published online: 27 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01463.x

    8. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya (pages e447–e452)

      H. N. Kim, J. Scott, A. Cent, L. Cook, R. A. Morrow, B. Richardson, K. Tapia, K. R. Jerome, G. Lule, G. John-Stewart and M. H. Chung

      Article first published online: 13 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01466.x

    9. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem (pages e453–e460)

      A. García-Fulgueiras, R. García-Pina, C. Morant, N. Fernández de Larrea-Baz and E. Álvarez

      Article first published online: 1 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01467.x

    10. Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients (pages e468–e474)

      A. Gramenzi, E. Loggi, L. Micco, C. Cursaro, S. Fiorino, S. Galli, S. Gitto, C. Galli, G. Furlini, M. Bernardi and P. Andreone

      Article first published online: 1 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01473.x

    11. Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance (pages e475–e481)

      J. W. Park, H. S. Kim, D. D. Seo, J. S. Jang, W. G. Shin, K. H. Kim, M. K. Jang, J. H. Lee, H. Y. Kim, D. J. Kim, M. S. Lee and C. K. Park

      Article first published online: 1 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01479.x

    12. Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C (pages e482–e490)

      C.-J. Liu, H.-R. Cheng, C.-L. Chen, T.-C. Chen, T.-C. Tseng, Z.-L. Wang, P.-J. Chen, C.-H. Liu, D.-S. Chen and J.-H. Kao

      Article first published online: 4 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01480.x

    13. Application of allele-specific RNAi in hepatitis B virus lamivudine resistance (pages e491–e498)

      X. Teng, J.-Y. Liu, D. Li, Y. Fang, X.-Y. Wang, Y.-X. Ma, S.-J. Chen, Y.-X. Zhao, W.-Z. Xu and H.-X. Gu

      Article first published online: 7 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01483.x

    14. The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes (pages e499–e507)

      R. Wilson, N. Warner, K. Ryan, L. Selleck, D. Colledge, S. Rodgers, K. Li, P. Revill and S. Locarnini

      Article first published online: 18 AUG 2011 | DOI: 10.1111/j.1365-2893.2011.01484.x

    15. Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B (pages e508–e515)

      S. Togo, M. Arai, A. Tawada, T. Chiba, T. Kanda, K. Fujiwara, F. Imazeki and O. Yokosuka

      Article first published online: 22 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01486.x

    16. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis (pages e516–e522)

      G. Nkontchou, M. Ziol, M. Aout, M. Lhabadie, Y. Baazia, A. Mahmoudi, D. Roulot, N. Ganne-Carrie, V. Grando-Lemaire, J.-C. Trinchet, E. Gordien, E. Vicaut, I. Baghad and M. Beaugrand

      Article first published online: 14 SEP 2011 | DOI: 10.1111/j.1365-2893.2011.01441.x

    17. A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease (pages e530–e534)

      A. K. P. Lim, N. Patel, R. J. Eckersley, J. Fitzpatrick, M. M. E. Crossey, G. Hamilton, R. D. Goldin, H. C. Thomas, W. Vennart, D. O. Cosgrove and S. D. Taylor-Robinson

      Article first published online: 4 APR 2011 | DOI: 10.1111/j.1365-2893.2011.01455.x

    18. Chronic hepatitis C in children – review of natural history at a National Centre (pages e535–e540)

      M. Abdel-Hady, S. K. Bunn, J. Sira, R. M. Brown, M. A. Brundler, P. Davies and D. A. Kelly

      Article first published online: 3 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01456.x

    19. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients (pages e541–e549)

      M. C. Roque-Cuéllar, B. Sánchez, J. R. García-Lozano, J. M. Praena-Fernández, A. Núñez-Roldán and J. Aguilar-Reina

      Article first published online: 14 SEP 2011 | DOI: 10.1111/j.1365-2893.2011.01464.x

    20. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma (pages e550–e560)

      T. Kawaoka, H. Aikata, S. Takaki, A. Hiramatsu, K. Waki, N. Hiraga, D. Miki, M. Tsuge, M. Imamura, Y. Kawakami, S. Takahashi, H. Ochi, H. Tashiro, H. Ohdan and K. Chayama

      Article first published online: 23 MAY 2011 | DOI: 10.1111/j.1365-2893.2011.01468.x

    21. Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes (pages e568–e577)

      S. Ghosh, W. A. Ahrens, S. U. Phatak, S. Hwang, L. W. Schrum and H. L. Bonkovsky

      Article first published online: 1 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01487.x

    22. Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors (pages e578–e582)

      S. Franco, R. Bellido, E. Aparicio, N. Cañete, M. García-Retortillo, R. Solà, C. Tural, B. Clotet, R. Paredes and M. A. Martínez

      Article first published online: 30 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01490.x

    23. Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism (pages e591–e602)

      S. U. Munshi, S. Taneja, N. S. Bhavesh, J. Shastri, R. Aggarwal and S. Jameel

      Article first published online: 1 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01488.x

    24. Effector T cells immune reactivity among patients with acute hepatitis E (pages e603–e608)

      M. M. Husain, R. Aggarwal, D. Kumar, S. Jameel and S. Naik

      Article first published online: 12 JUL 2011 | DOI: 10.1111/j.1365-2893.2011.01489.x

SEARCH

SEARCH BY CITATION